Vir Biotechnology, Inc. (VIR)
10.36
-0.05
(-0.48%)
USD |
NASDAQ |
Oct 15, 11:52
Vir Biotechnology Total Long Term Debt (Quarterly) : 84.14M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 84.14M |
| March 31, 2026 | 86.64M |
| December 31, 2025 | 89.05M |
| September 30, 2025 | 91.22M |
| June 30, 2025 | 93.40M |
| March 31, 2025 | 88.17M |
| December 31, 2024 | 90.14M |
| September 30, 2024 | 93.40M |
| June 30, 2024 | 95.02M |
| March 31, 2024 | 109.17M |
| December 31, 2023 | 111.67M |
| September 30, 2023 | 114.12M |
| June 30, 2023 | 117.82M |
| March 31, 2023 | 121.46M |
| December 31, 2022 | 123.84M |
| September 30, 2022 | 126.94M |
| Date | Value |
|---|---|
| June 30, 2022 | 130.20M |
| March 31, 2022 | 132.81M |
| December 31, 2021 | 133.56M |
| September 30, 2021 | 68.60M |
| June 30, 2021 | 68.94M |
| March 31, 2021 | 66.62M |
| December 31, 2020 | 67.52M |
| September 30, 2020 | 13.04M |
| June 30, 2020 | 13.81M |
| March 31, 2020 | 14.57M |
| December 31, 2019 | 1.137M |
| September 30, 2019 | 637.71M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Moderna, Inc. | 1.266B |
| Vaxcyte, Inc. | 108.94M |
| Caribou Biosciences, Inc. | 25.28M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |
| Oncolytics Biotech, Inc. | 0.31M |